• OPEN AN ACCOUNT
Indian Indices
Sensex
74,294.96 -19.63
( -0.03%)
Global Indices
Nasdaq
51,795.38 312.48
(0.61%)
Dow Jones
7,657.54 84.73
(1.12%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,816.25 127.78
(1.20%)
Forex
USD-INR
95.66 0.25
(0.26%)
EUR-INR
110.22 0.12
(0.11%)
GBP-INR
128.62 0.00
(0.00%)
JPY-INR
0.62 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3553764
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
33.81
110858.38
EPS(TTM)
Face Value()
Div & Yield %
40.59
2
0.95
 

Linc consolidated net profit declines 13.63% in the March 2026 quarter
May 27,2026
Net profit of Linc declined 13.63% to Rs 10.46 crore in the quarter ended March 2026 as against Rs 12.11 crore during the previous quarter ended March 2025. Sales declined 10.56% to Rs 137.67 crore in the quarter ended March 2026 as against Rs 153.93 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.93% to Rs 32.74 crore in the year ended March 2026 as against Rs 38.04 crore during the previous year ended March 2025. Sales declined 0.09% to Rs 543.01 crore in the year ended March 2026 as against Rs 543.48 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales137.67153.93 -11 543.01543.48 0
OPM %12.9112.50 -10.9511.85 -
PBDT19.4320.45 -5 64.6166.16 -2
PBT15.7116.86 -7 49.5151.21 -3
NP10.4612.11 -14 32.7438.04 -14